This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Giovannucci, E. Articles by Willett, W. C. Search for Related Content PubMed PubMed Citation Articles by Giovannucci, E. Articles by Willett, W. C.

Smoking and Risk of Total and Fatal Prostate Cancer in United States Health Professionals¹

Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115 [E. G., E. B. R., G. A. C., M. J. S., W. C. W.], and Departments of Nutrition [E. G., E. B. R., A. A., M. J. S., W. C. W.], Epidemiology [E. G., E. B. R., A. A., G. A. C., D. S., M. J. S., W. C. W.], and Biostatistics [D. S.], Harvard School of Public Health, Boston, Massachusetts 02115

Studies that have examined the relationship between cigarette use and prostate cancer incidence have yielded inconsistent results, although most studies have suggested that smoking is related to the occurrence of fatal prostate cancer. We evaluated prospectively the relationship between cigarette smoking and total, distant metastatic, and fatal prostate cancer in 47,781 male health professionals throughout the United States followed with questionnaires. From 1986 to 1994, we documented 1369 men with prostate cancer (excluding stage A1). One hundred fifty-two of the men had distant metastatic disease at diagnosis, and 103 fatal cases occurred from 1986 to 1994. Early (before age 30), late (within recent 10 years), and lifetime cumulative smoking history were unrelated to risk of total prostate cancer. However, men who had smoked 15 or more pack-years of cigarettes within the preceding 10 years were at higher risk of distant metastatic prostate cancer [multivariate relative risk (RR), 1.81; 95% confidence interval (CI), 1.05–3.11; P (trend), 0.03] and fatal prostate cancer [RR, 2.06; CI, 1.08–3.90; P (trend), 0.02] relative to nonsmokers. Within 10 years after quitting, the excess risk among smokers is eliminated. The higher rate of fatal prostate cancer among smokers did not appear to result from confounding by diet or other lifestyle factors, different screening behavior between smokers and nonsmokers, or from other smoking-related comorbidities. Our results indicate that although smoking was unrelated to prostate cancer incidence, recent tobacco use had a substantial impact on the occurrence of fatal prostate cancer.

This article has been cited by other articles:

				S. Koutros, A. J. Cross, D. P. Sandler, J. A. Hoppin, X. Ma, T. Zheng, M. C.R. Alavanja, and R. Sinha Meat and Meat Mutagens and Risk of Prostate Cancer in the Agricultural Health Study Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 80 - 87. [Abstract] [Full Text] [PDF]

				S. T. Okino, L. C. Quattrochi, D. Pookot, M. Iwahashi, and R. Dahiya A Dioxin-Responsive Enhancer 3' of the Human CYP1A2 Gene Mol. Pharmacol., December 1, 2007; 72(6): 1457 - 1465. [Abstract] [Full Text] [PDF]

				K. A. Lawson, M. E. Wright, A. Subar, T. Mouw, A. Hollenbeck, A. Schatzkin, and M. F. Leitzmann Multivitamin Use and Risk of Prostate Cancer in the National Institutes of Health-AARP Diet and Health Study J Natl Cancer Inst, May 16, 2007; 99(10): 754 - 764. [Abstract] [Full Text] [PDF]

				C. M. Nagle, C. J. Bain, and P. M. Webb Cigarette Smoking and Survival after Ovarian Cancer Diagnosis Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2557 - 2560. [Abstract] [Full Text] [PDF]

				J. Park, L. Chen, L. Ratnashinge, T. A. Sellers, J.-P. Tanner, J.-H. Lee, N. Dossett, N. Lang, F. F. Kadlubar, C. B. Ambrosone, et al. Deletion Polymorphism of UDP-Glucuronosyltransferase 2B17 and Risk of Prostate Cancer in African American and Caucasian Men. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1473 - 1478. [Abstract] [Full Text] [PDF]

				K. L. Lockett, M.C. Hall, P. E. Clark, S.-C. Chuang, B. Robinson, H.-Y. Lin, L.J. Su, and J. J. Hu DNA damage levels in prostate cancer cases and controls Carcinogenesis, June 1, 2006; 27(6): 1187 - 1193. [Abstract] [Full Text] [PDF]

				A. Kjaerbye-Thygesen, K. Frederiksen, E. V. Hogdall, E. Glud, L. Christensen, C. K. Hogdall, J. Blaakaer, and S. K. Kjaer Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 798 - 803. [Abstract] [Full Text] [PDF]

				I-M. Lee, J. M. Gaziano, and J. E. Buring Vitamin E in the prevention of prostate cancer: where are we today? J Natl Cancer Inst, February 15, 2006; 98(4): 225 - 227. [Full Text] [PDF]

				V. A. Kirsh, R. B. Hayes, S. T. Mayne, N. Chatterjee, A. F. Subar, L. B. Dixon, D. Albanes, G. L. Andriole, D. A. Urban, and U. Peters Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst, February 15, 2006; 98(4): 245 - 254. [Abstract] [Full Text] [PDF]

				J. J. Hu, M. C. Hall, L. Grossman, M. Hedayati, D. L. McCullough, K. Lohman, and L. D. Case Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk Cancer Res., February 1, 2004; 64(3): 1197 - 1201. [Abstract] [Full Text] [PDF]

				P. Vineis, M. Alavanja, P. Buffler, E. Fontham, S. Franceschi, Y. T. Gao, P. C. Gupta, A. Hackshaw, E. Matos, J. Samet, et al. Tobacco and Cancer: Recent Epidemiological Evidence J Natl Cancer Inst, January 21, 2004; 96(2): 99 - 106. [Full Text] [PDF]

				C. M. Tammemagi, C. Neslund-Dudas, M. Simoff, and P. Kvale Smoking and Lung Cancer Survival: The Role of Comorbidity and Treatment Chest, January 1, 2004; 125(1): 27 - 37. [Abstract] [Full Text] [PDF]

				A. H. Conney Enzyme Induction and Dietary Chemicals as Approaches to Cancer Chemoprevention: The Seventh DeWitt S. Goodman Lecture Cancer Res., November 1, 2003; 63(21): 7005 - 7031. [Abstract] [Full Text] [PDF]

				L. A. Plaskon, D. F. Penson, T. L. Vaughan, and J. L. Stanford Cigarette Smoking and Risk of Prostate Cancer in Middle-Aged Men Cancer Epidemiol. Biomarkers Prev., July 1, 2003; 12(7): 604 - 609. [Abstract] [Full Text] [PDF]

				M. C. R. Alavanja, C. Samanic, M. Dosemeci, J. Lubin, R. Tarone, C. F. Lynch, C. Knott, K. Thomas, J. A. Hoppin, J. Barker, et al. Use of Agricultural Pesticides and Prostate Cancer Risk in the Agricultural Health Study Cohort Am. J. Epidemiol., May 1, 2003; 157(9): 800 - 814. [Abstract] [Full Text] [PDF]

				E. Giovannucci {{gamma}}-Tocopherol: a New Player in Prostate Cancer Prevention? J Natl Cancer Inst, December 20, 2000; 92(24): 1966 - 1967. [Full Text] [PDF]

				E. A. Platz, E. B. Rimm, W. C. Willett, P. W. Kantoff, and E. Giovannucci Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health Professionals J Natl Cancer Inst, December 20, 2000; 92(24): 2009 - 2017. [Abstract] [Full Text] [PDF]

				P. Stattin, A. Bylund, S. Rinaldi, C. Biessy, H. Dechaud, U.-H. Stenman, L. Egevad, E. Riboli, G. Hallmans, and R. Kaaks Plasma Insulin-Like Growth Factor-I, Insulin-Like Growth Factor-Binding Proteins, and Prostate Cancer Risk: a Prospective Study J Natl Cancer Inst, December 6, 2000; 92(23): 1910 - 1917. [Abstract] [Full Text] [PDF]

				T. F. Shepard, E. A. Platz, P. W. Kantoff, W. G. Nelson, W. B. Isaacs, D. Freije, P. G. Febbo, M. J. Stampfer, and E. Giovannucci No Association between the I105V Polymorphism of the Glutathione S-Transferase P1 Gene (GSTP1) and Prostate Cancer Risk: A Prospective Study Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1267 - 1268. [Full Text]

				A. M. Y. Nomura, J. Lee, G. N. Stemmermann, and G. F. Combs Jr. Serum Selenium and Subsequent Risk of Prostate Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2000; 9(9): 883 - 887. [Abstract] [Full Text]

				J. M. Chan, M. J. Stampfer, J. Ma, E. B. Rimm, W. C. Willett, and E. L. Giovannucci Supplemental Vitamin E Intake and Prostate Cancer Risk in a Large Cohort of Men in the United States Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 893 - 899. [Abstract] [Full Text]